Design and Optimization of the Single-Stage Continuous Mixed Suspension–Mixed Product Removal Crystallization of 2‑Chloro‑N‑(4-methylphenyl)propenamide

A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)­propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key...

Full description

Saved in:
Bibliographic Details
Published inACS omega Vol. 7; no. 16; pp. 13676 - 13686
Main Authors Pascual, Gladys Kate, Donnellan, Philip, Glennon, Brian, Wood, Barbara, Jones, Roderick C
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 26.04.2022
Online AccessGet full text
ISSN2470-1343
2470-1343
DOI10.1021/acsomega.1c07228

Cover

Abstract A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)­propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.
AbstractList A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro- -(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.
A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro- N -(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.
A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.
A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of 2-chloro-N-(4-methylphenyl)­propanamide (CNMP) in toluene from 25 to 0 °C. The conversion of the previous batch to a continuous process was key to developing a methodology linking the synthesis and purification unit operations of CNMP and gave further insight in the development of continuous process trains for active pharmaceutical ingredient materials. By monitoring how parameters such as cooling and agitation rates influence particle size and the yield, two batch start-up strategies were compared. The second part of the study focused on developing and optimizing the continuous cooling crystallization of CNMP in the MSMPR crystallizer in relation to the yield by determining the effects of varying the residence time and the agitation rates. During the MSMPR operation, the plot of the focused beam reflectance measurement total counts versus time oscillates and reaches an unusual state of control. Despite the oscillations, the dissolved concentration was constant. The yield and production rate from the system were constant after two residence times, as supported by FTIR data. The overall productivity was higher at shorter residence times (τ), and a productivity of 69.51 g/h for τ = 20 min was achieved for the isolation of CNMP.
Author Jones, Roderick C
Donnellan, Philip
Pascual, Gladys Kate
Glennon, Brian
Wood, Barbara
AuthorAffiliation APC Ltd
Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering
AuthorAffiliation_xml – name: APC Ltd
– name: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering
Author_xml – sequence: 1
  givenname: Gladys Kate
  surname: Pascual
  fullname: Pascual, Gladys Kate
  organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering
– sequence: 2
  givenname: Philip
  orcidid: 0000-0001-8576-7857
  surname: Donnellan
  fullname: Donnellan, Philip
  organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering
– sequence: 3
  givenname: Brian
  surname: Glennon
  fullname: Glennon, Brian
  organization: APC Ltd
– sequence: 4
  givenname: Barbara
  surname: Wood
  fullname: Wood, Barbara
  email: Barbara.wood@approcess.com
  organization: APC Ltd
– sequence: 5
  givenname: Roderick C
  orcidid: 0000-0002-2884-4884
  surname: Jones
  fullname: Jones, Roderick C
  email: Roderick.jones@ucd.ie
  organization: Synthesis and Solid State Pharmaceutical Centre (SSPC), School of Chemical and Bioprocess Engineering
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35559147$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1TAQhSNUREvpnhXKskik2E7iOBskFH6lQhEX1pbjTBJXjp3aTsVl1VdAPADv1ifBcG-rCxIsLI883zljzbmf7BlrIEkeYnSCEcFPhfR2gkGcYIkqQtid5IAUFcpwXuR7O_V-cuT9OUIIU0YYofeS_bwsyxoX1UHy4wV4NZhUmC49m4Oa1FcRlDWp7dMwQrpSZtCQrYIYIG2sCcosdvHpO_UFunS1-BmMj_z11ffN0wdnu0WG9CNM9lLotHFrH4TWO77k-upbM2rrbCzex3NcZBOEca3nEcxaP56djbZiUh08SO72Qns42t6HyedXLz81b7LTs9dvm-enmchpHjJoCwaso4QUkrWAUUfrsqQScNV1VZszQijp85LhivYtSNIjTLqKibJmNenr_DB5tvGdl3aCToIJTmg-OzUJt-ZWKP5nx6iRD_aS14ixuiDR4Hhr4OzFAj7wSXkJWgsDcWGcUFowlNcljeij3Vm3Q25SiQDaANJZ7x30twhG_Ff2_CZ7vs0-SuhfEqnC743H3yr9P-GTjTB2-LldnIlr_jf-E0uezMg
CitedBy_id crossref_primary_10_3390_cryst14121021
crossref_primary_10_1016_j_cherd_2023_01_020
Cites_doi 10.1002/aic.690230415
10.1002/ejoc.201700871
10.1021/acs.oprd.5b00325
10.1021/acs.oprd.5b00001
10.1021/cg401904a
10.1016/j.ces.2015.02.014
10.1002/anie.201409318
10.1016/j.cep.2015.01.001
10.1002/ceat.201700427
10.1021/acs.jced.7b00288
10.1021/op900237x
10.1021/op200347k
10.1021/acs.cgd.5b01290
10.1039/c0cc05060a
10.1016/j.jiec.2017.06.009
10.1016/J.ENG.2017.03.023
10.1021/acs.oprd.8b00440
10.1039/c0ob00368a
10.1021/acs.oprd.5b00139
10.1016/j.ces.2013.09.006
10.1208/s12249-017-0819-9
10.1002/ejoc.201900184
10.1002/ejoc.201900494
10.1039/C5CS00902B
10.1016/j.tet.2010.04.057
10.1021/acs.oprd.8b00319
10.1002/aic.16466
10.1107/S2056989018013889
10.1007/s12247-015-9215-8
10.1021/cg101556s
10.1039/c0ob00805b
10.1016/j.tetasy.2010.05.004
10.1038/nchem.1753
ContentType Journal Article
Copyright 2022 The Authors. Published by American Chemical Society
2022 The Authors. Published by American Chemical Society.
2022 The Authors. Published by American Chemical Society 2022 The Authors
Copyright_xml – notice: 2022 The Authors. Published by American Chemical Society
– notice: 2022 The Authors. Published by American Chemical Society.
– notice: 2022 The Authors. Published by American Chemical Society 2022 The Authors
DBID N~.
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1021/acsomega.1c07228
DatabaseName American Chemical Society (ACS) Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: N~.
  name: American Chemical Society (ACS) Open Access
  url: https://pubs.acs.org
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2470-1343
EndPage 13686
ExternalDocumentID PMC9088942
35559147
10_1021_acsomega_1c07228
c161439138
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: NA
– fundername: ;
  grantid: 12/RC/2275
GroupedDBID 53G
ABFRP
ABUCX
ACS
ADACO
ADBBV
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
EBS
GROUPED_DOAJ
HYE
N~.
OK1
RPM
VF5
AAFWJ
AAHBH
AAYXX
ABBLG
ADUCK
AFPKN
CITATION
M~E
NPM
7X8
5PM
ID FETCH-LOGICAL-a363t-eb48e8d6224c8be10d69556ce17dd7b382262f358176fbec2f012d78a59892f93
IEDL.DBID ACS
ISSN 2470-1343
IngestDate Thu Aug 21 18:12:14 EDT 2025
Fri Jul 11 10:07:33 EDT 2025
Mon Jul 21 05:46:19 EDT 2025
Tue Jul 01 01:06:15 EDT 2025
Thu Apr 24 23:03:36 EDT 2025
Thu Apr 28 04:09:17 EDT 2022
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
License https://creativecommons.org/licenses/by/4.0
2022 The Authors. Published by American Chemical Society.
Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a363t-eb48e8d6224c8be10d69556ce17dd7b382262f358176fbec2f012d78a59892f93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8576-7857
0000-0002-2884-4884
OpenAccessLink https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1021/acsomega.1c07228
PMID 35559147
PQID 2664803956
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9088942
proquest_miscellaneous_2664803956
pubmed_primary_35559147
crossref_primary_10_1021_acsomega_1c07228
crossref_citationtrail_10_1021_acsomega_1c07228
acs_journals_10_1021_acsomega_1c07228
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-04-26
PublicationDateYYYYMMDD 2022-04-26
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-26
  day: 26
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS omega
PublicationTitleAlternate ACS Omega
PublicationYear 2022
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
Gutmann B. (ref6/cit6) 2015; 33
ref32/cit32
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref34/cit34
ref28/cit28
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref7/cit7
References_xml – ident: ref35/cit35
  doi: 10.1002/aic.690230415
– ident: ref10/cit10
  doi: 10.1002/ejoc.201700871
– volume: 33
  start-page: 18
  issue: 3
  year: 2015
  ident: ref6/cit6
  publication-title: Chim. Oggi
– ident: ref5/cit5
  doi: 10.1021/acs.oprd.5b00325
– ident: ref12/cit12
  doi: 10.1021/acs.oprd.5b00001
– ident: ref14/cit14
  doi: 10.1021/cg401904a
– ident: ref16/cit16
  doi: 10.1016/j.ces.2015.02.014
– ident: ref3/cit3
  doi: 10.1002/anie.201409318
– ident: ref31/cit31
  doi: 10.1016/j.cep.2015.01.001
– ident: ref17/cit17
  doi: 10.1002/ceat.201700427
– ident: ref20/cit20
  doi: 10.1021/acs.jced.7b00288
– ident: ref27/cit27
  doi: 10.1021/op900237x
– ident: ref1/cit1
  doi: 10.1021/op200347k
– ident: ref30/cit30
  doi: 10.1021/acs.cgd.5b01290
– ident: ref11/cit11
  doi: 10.1039/c0cc05060a
– ident: ref34/cit34
  doi: 10.1016/j.jiec.2017.06.009
– ident: ref26/cit26
  doi: 10.1016/J.ENG.2017.03.023
– ident: ref2/cit2
  doi: 10.1021/acs.oprd.8b00440
– ident: ref23/cit23
  doi: 10.1039/c0ob00368a
– ident: ref15/cit15
  doi: 10.1021/acs.oprd.5b00139
– ident: ref28/cit28
  doi: 10.1016/j.ces.2013.09.006
– ident: ref33/cit33
  doi: 10.1208/s12249-017-0819-9
– ident: ref8/cit8
  doi: 10.1002/ejoc.201900184
– ident: ref22/cit22
  doi: 10.1002/ejoc.201900494
– ident: ref9/cit9
  doi: 10.1039/C5CS00902B
– ident: ref21/cit21
  doi: 10.1016/j.tet.2010.04.057
– ident: ref13/cit13
  doi: 10.1021/acs.oprd.8b00319
– ident: ref29/cit29
– ident: ref18/cit18
  doi: 10.1002/aic.16466
– ident: ref19/cit19
  doi: 10.1107/S2056989018013889
– ident: ref4/cit4
  doi: 10.1007/s12247-015-9215-8
– ident: ref32/cit32
  doi: 10.1021/cg101556s
– ident: ref24/cit24
  doi: 10.1039/c0ob00805b
– ident: ref25/cit25
  doi: 10.1016/j.tetasy.2010.05.004
– ident: ref7/cit7
  doi: 10.1038/nchem.1753
SSID ssj0001682826
Score 2.1986697
Snippet A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of...
A continuously operated single-stage mixed suspension-mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of...
A continuously operated single-stage mixed suspension–mixed product removal (MSMPR) crystallizer was developed for the continuous cooling crystallization of...
SourceID pubmedcentral
proquest
pubmed
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 13676
Title Design and Optimization of the Single-Stage Continuous Mixed Suspension–Mixed Product Removal Crystallization of 2‑Chloro‑N‑(4-methylphenyl)propenamide
URI http://dx.doi.org/10.1021/acsomega.1c07228
https://www.ncbi.nlm.nih.gov/pubmed/35559147
https://www.proquest.com/docview/2664803956
https://pubmed.ncbi.nlm.nih.gov/PMC9088942
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVABC
  databaseName: American Chemical Society (ACS) Open Access
  customDbUrl:
  eissn: 2470-1343
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001682826
  issn: 2470-1343
  databaseCode: N~.
  dateStart: 20160731
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org
  providerName: American Chemical Society
– providerCode: PRVABC
  databaseName: American Chemical Society Journals
  customDbUrl:
  eissn: 2470-1343
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001682826
  issn: 2470-1343
  databaseCode: ACS
  dateStart: 20160731
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals
  providerName: American Chemical Society
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2470-1343
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001682826
  issn: 2470-1343
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2470-1343
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001682826
  issn: 2470-1343
  databaseCode: M~E
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2470-1343
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001682826
  issn: 2470-1343
  databaseCode: RPM
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3datswFBZbd7Hd7H9d9lM02GC9UCrJsixfFq-lDJKNZYXeGVuS2zDHDnEMyy5KX2HsAfZufZId2U7atKP0wsLIkkDSkc8nnaPvIPSeaam0FJZoKSkRGSSKUUpCmVKmA8ho7nEPhvLgUHw-8o8uaHKuWvA520l0VU7scdJnmgacq7voHpeKuY3WbjS6OE-RsHdooqtxEVDCPOF1Vsn_NeJ0ka7WddE1gHnVT_KS4tl_1EYwqhq-Qudv8qNfz9O-_nWdzfEWfXqMHnb4E--2AvME3bHFU3Q_WoZ9e4b-fmp8OnBSGPwF_ieT7qImLjMMYBGPQNfllgBIPbbYcVuNi7qsKzwY_7QGj-pq6lziy-L87E-b9bXllMXf7KQEscbRbAGINM8vtcvPz35HJ3k5K-FlCM9HQVxo60XuPNAW-fbUmQyKZDI29jk63N_7Hh2QLooDSTzpzYlNhbLKSMAKWqWWUSND35fassCYIPUAoUieORq2QGYgUTwDnWkClfihCnkWei_QRlEW9iXCCaAXk1lDU-tgnAlpqH3KjPGyTHo66KEPMLJxtwqruDGwcxYvhzvuhruHdpbzHuuOCt1F5MhvqLG9qjFtaUBuKPtuKUoxzJ0zwCSFhZmIAQwJRT3YkvbQZitaq9YA9_khE9CHYE3oVgUcD_j6l2J80vCBN65qgr-6Ze9fowfc3eGggnD5Bm3MZ7V9C8hqnm41S2qrOZeAdHC6B-nwtP8P5SkqIw
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGeBgv3C_laiSQ2IM723Gc5BEFpgJrQesm7S1KbGerSJOqaSTK0_4C4gfw3_ZLOM6lWwea4CFR5NiWL8c5n3OOv4PQK6akr6QwRElJiUjh5jNKSSATypQHCfU57uFIDg7FxyP3aAOx7iwMNKKEmsraiH_OLsB2IK2YmuO4zxT1OPevoes1EYpFQ-H4_LeKhC1EHWSNC48S5ginNU7-rRKrklS5rpL-wJmX3SUv6J_dW2h_1fLa7eRrv1okffX9Eqnjf3XtNrrZolH8thGfO2jD5HfRVtgFgbuHfr2rPTxwnGv8Gb4u0_bYJi5SDNARj0HzZYYAZD022DJdTfKqqEo8nHwzGo-rcmYd5Iv87PRnk_SlYZjF-2ZagJDjcL4EfJplF-rlZ6c_wpOsmBfwMILrjSA20PUys_5oy2x7Zg0IeTydaHMfHe6-PwgHpI3pQGJHOgtiEuEbX0tADspPDKNaBq4rlWGe1l7iAF6RPLWkbJ5MQb54ChpUe37sBn7A08B5gDbzIjePEI4By-jUaJoYC-p0QAPlUqa1k6bSUV4PvYaRjdo1WUa1uZ2zqBvuqB3uHtrppj9SLTG6jc-RXVFie1Vi1pCCXJH3ZSdREcydNcfEuYGZiAAaCZ86sEHtoYeNhK1qAxToBkxAH7w12VtlsKzg62_yyUnNDl47rgn--B97_wJtDQ6Ge9Heh9GnJ-gGt6c7qCBcPkWbi3llngHmWiTP61X2G9j7L00
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB5qC-pLab2uVh1BwT5MO7dMkkfZutRL12It9C0kc2kXssnS7EL3RfoXxB_gf-sv8Uwua1el-JAQJjOHDOdMzjdzbgi9YlpFWklLtFKUSAe3iFFKYpVRpkNoqOO4D4Zq_1h-OAlOVlDQxcLAR1RAqaqN-H5VT4xrMwywXWgvx_Y03WGahpxHt9Aa4BHhxXv4bef30YqCbURdaI3LkBImpGgNlP8i4tWSrpbV0l9Y80-XyWs6aLCB1lvwiN823N5EK7a4h-70u5pt99HPvdohA6eFwZ_hZzBuoyxx6TAgPXwEiiq3BBDmqcU-MdWomMHWHx-MLqzBR7Nq4v3Zy-Lq8kfTdNgkhMVf7LgEmcT98znAyTy_RpdfXX7vn8G2v4SHIVxvJPF1qee5dx-b59sTf97v694b-wAdD9597e-TtgQDSYUSU2IzGdnIKFD0Ososo0bFQaC0ZaExYSYAXijufA61UDkQB-5A4ZkwSoM4irmLxUO0WpSFfYxwCtDDOGtoZj0GMzGNdUCZMcI5JXTYQ6-BD0m7hKqkto5zlnT8Slp-9dBux6lEt3nMfTmN_IYR24sRkyaHxw19X3bMT4B33nqSFhY4kQCSkREVsJ_soUeNMCyoAWgLYiZhDuGSmCw6-CTey2-K0VmdzLv2M5P8yX_O_gW6fbg3SD69H358iu5yH4tBJeFqC61Oz2f2GSCkafa8Xg-_AJPWFHk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Optimization+of+the+Single-Stage+Continuous+Mixed+Suspension%E2%80%93Mixed+Product+Removal+Crystallization+of+2%E2%80%91Chloro%E2%80%91N%E2%80%91%284-methylphenyl%29propenamide&rft.jtitle=ACS+omega&rft.au=Pascual%2C+Gladys+Kate&rft.au=Donnellan%2C+Philip&rft.au=Glennon%2C+Brian&rft.au=Wood%2C+Barbara&rft.date=2022-04-26&rft.pub=American+Chemical+Society&rft.issn=2470-1343&rft.eissn=2470-1343&rft.volume=7&rft.issue=16&rft.spage=13676&rft.epage=13686&rft_id=info:doi/10.1021%2Facsomega.1c07228&rft.externalDocID=c161439138
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2470-1343&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2470-1343&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2470-1343&client=summon